Levonantradol is a synthetic cannabinoid analog of dronabinol developed by Pfizer in the 1980s. It is around 30 times more potent than THC, and exhibits antiemetic and analgesic effects via activation of CB₁ and CB₂ cannabinoid receptors. Wikipedia